Taoka Chemical Company, Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Taoka Chemical Company, Limited (TSE:4113) just released its yearly report and things are looking bullish. It was overall a positive result, with revenues beating expectations by 2.2% to hit JP¥30b. Taoka Chemical Company reported statutory earnings per share (EPS) JP¥103, which was a notable 18% above what the analyst had forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analyst is forecasting for next year, and see if there's been a change in sentiment towards the company. So we gathered the latest post-earnings forecasts to see what estimate suggests is in store for next year.

We've discovered 2 warning signs about Taoka Chemical Company. View them for free.

Taking into account the latest results, the consensus forecast from Taoka Chemical Company's single analyst is for revenues of JP¥36.0b in 2026. This reflects a sizeable 20% improvement in revenue compared to the last 12 months. Per-share earnings are expected to swell 20% to JP¥124. In the lead-up to this report, the analyst had been modelling revenues of JP¥32.6b and earnings per share (EPS) of JP¥119 in 2026. Sentiment certainly seems to have improved after the latest results, with a nice gain to revenue and a small lift in earnings per share estimates.

Check out our latest analysis for Taoka Chemical Company

It will come as no surprise to learn that the analyst has increased their price target for Taoka Chemical Company 5.9% to JP¥1,800on the back of these upgrades.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Taoka Chemical Company's past performance and to peers in the same industry. For example, we noticed that Taoka Chemical Company's rate of growth is expected to accelerate meaningfully, with revenues forecast to exhibit 20% growth to the end of 2026 on an annualised basis. That is well above its historical decline of 0.6% a year over the past five years. Compare this against analyst estimates for the broader industry, which suggest that (in aggregate) industry revenues are expected to grow 4.6% annually. Not only are Taoka Chemical Company's revenues expected to improve, it seems that the analyst is also expecting it to grow faster than the wider industry.

The Bottom Line

The most important thing here is that the analyst upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Taoka Chemical Company following these results. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. We note an upgrade to the price target, suggesting that the analyst believes the intrinsic value of the business is likely to improve over time.

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At least one analyst has provided forecasts out to 2028, which can be seen for free on our platform here.

We don't want to rain on the parade too much, but we did also find 2 warning signs for Taoka Chemical Company that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.